Back to top

MTN-037 is a Phase I study evaluating whether a microbicide gel called PC-1005 is safe for use in the rectum. The study, which will include approximately 12 HIV-uninfected cisgender and transgender men and women at two sites in the United States, will help determine whether further testing on the safety and acceptability of PC-1005 as a potential rectal microbicide for preventing HIV and other sexually transmitted infections (STIs) can be conducted in a larger population. Results are anticipated by mid-2019.

 

See

MTN-037 Backgrounder

19-June-2018